BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 30, 2004
View Archived Issues
Biogen Idec's Antegren Positive In Maintenance Trial For Crohn's
Despite a failed trial last year, Antegren now has garnered some positive Phase III data, meeting its primary endpoint by maintaining a response in Crohn's disease patients. (BioWorld Today)
Read More
MedImmune Revenues Top $1B As Firm Sorts FluMist Options
Read More
Labopharm Reports Mixed Data For Tramadol, Plans NDA Filing
Read More
Chiron Earnings Rise Due To Vaccine, Other Product Growth
Read More
Other News To Note
Read More
Appointments And Advancements
Read More